Biorepository for liver disease samples
Official title: Virology, Immunology and Mechanisms of Liver Disease in Patients With Hepatitis C and Other Liver Diseases
Run by State University of New York at Buffalo · NCT03025074 · Data updated 2026-11-12
This study is collecting samples from patients with liver diseases to help researchers find better treatments and improve care for these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | State University of New York at Buffalo Academic / other |
| Locations | 1 site (Buffalo, New York) |
| Status | Recruiting |
| Started | July 2013 |
| Main results expected | December 2099 |
| Study ends | December 2099 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT03025074 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with liver diseases such as NASH, Hepatitis C, and Hepatitis B, as well as healthy controls.
✕Probably not a fit
Patients who are unable to consent, including infants, pregnant women, and prisoners, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This biorepository at the University at Buffalo aims to collect high-quality biological samples from patients with various liver diseases, including Non-Alcoholic Steatohepatitis (NASH), Hepatitis C, and Hepatitis B. The initiative is designed to foster collaboration between clinicians and researchers, enhance training for junior investigators, and promote multidisciplinary approaches in translational medicine. By providing these specimens, the biorepository supports research efforts aimed at discovering new treatments and improving patient care for liver diseases. The goal is to create a comprehensive resource of clinically annotated samples from patients in Western New York.
Why it matters
Potential benefit: If successful, this biorepository could significantly advance research and treatment options for patients suffering from liver diseases.
How similar studies have gone: Other biorepositories focused on liver diseases have shown success in advancing research, making this approach both valuable and tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples. * Children and teenagers will be special populations considered in this protocol. Exclusion Criteria: * Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.
Where it's running
-
University at Buffalo, Buffalo General Medical Center
Buffalo, New York, United States Recruiting
Study contacts
- Principal investigator: Andrew Talal, MD — University at Buffalo
- Study coordinator: Barbara Bauer, BA
- Email: bmbauer@buffalo.edu
- Phone: 716-888-4825
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Copper supplementation for people with cirrhosis
This trial will try giving copper supplements to adults with cirrhosis who have low copper levels or signs of copper deficiency to see if liver-related health improves.
-
Screening for hepatitis B, hepatitis C and HIV using a dried blood spot
This project will try a simple dried blood spot test to check people who use drugs for hepatitis B, hepatitis C and HIV.
-
Collecting blood samples from healthy individuals and patients with cancer or benign diseases
This study is collecting blood samples from healthy people and patients with cancer or non-cancer conditions to see if certain DNA markers can help detect cancer more accurately.
-
How chronic liver diseases connect with other long-term illnesses
We will look back at hospital records to see if chronic liver diseases are linked with other systemic illnesses in adults who visited Tzu Chi gastroenterology clinics.
-
Observational cohort for non-alcoholic fatty liver disease and related conditions
This study is trying to learn more about non-alcoholic fatty liver disease and its related conditions by looking at patients with different stages of the disease and comparing them to people with diabetes and obesity who don't have it.
-
Evaluation of patients with liver disease
This study is trying to learn more about liver diseases by checking in on patients with conditions like hepatitis B, C, and D through regular tests and follow-ups.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.